ASCO AI Taskforce: Responsible AI in Cancer Care With: Dr. Debra Patt
Dr. Debra Patt, Chair of the AI Taskforce at the American Society of Clinical Oncology (ASCO), discusses the organization’s guidelines for responsible AI use in cancer care. While ASCO recognizes AI’s potential to improve decision-making, Patt emphasizes transparency, bias awareness, and keeping physicians central in care delivery. She illustrates with a clinical example how AI recommendations may overlook patient-specific factors, reinforcing the need for human oversight. AI can offer valuable nudges or decision-support suggestions, but ultimate care choices must remain personalized and patient-centered.
Episode Contents:
About the Guest
Dr. Debra Patt is EVP of Policy and Strategy at Texas Oncology and Chair of the AI Taskforce at ASCO. Learn more at: https://www.linkedin.com/in/debrapattmd/
Key Takeaways
- ASCO published guidelines for responsible AI in cancer care.
- Transparency, bias awareness, and hallucination control are key.
- Doctors must remain central to care decisions despite AI input.
Transcript Summary
What is ASCO’s stance on AI in oncology?
There is excitement for AI’s potential, but with strong caution. ASCO has published guidelines for responsible AI use.
What do these guidelines emphasize?
Transparency about AI models, keeping doctors central, understanding biases, and managing hallucinations.
Can AI replace clinical judgment?
No. AI can guide decisions, but doctors must personalize care based on patient needs, such as avoiding treatments that harm quality of life.
More Topics
- AI in the Healthcare Industry
- AI and Medical Innovation
- Healthcare Ethics and Policy
- AI in Patient Care
Keep Exploring
About the Series
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine.
Dr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine.
Mika Newton is an expert in healthcare data management, with a focus on data completeness and universality. Mika is on the editorial board of AI in Precision Oncology and is no stranger to bringing transformative technologies to market and fostering innovation.